Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
0.6800
-0.0168 (-2.41%)
Aug 4, 2026, 11:43 AM EDT - Market open
Inovio Pharmaceuticals Employees
Inovio Pharmaceuticals had 112 employees as of December 31, 2025. The number of employees decreased by 22 or -16.42% compared to the previous year.
Employees
112
Change (1Y)
-22
Growth (1Y)
-16.42%
Revenue / Employee
n/a
Profits / Employee
-$758,339
Market Cap
55.95M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 112 | -22 | -16.42% |
| Dec 31, 2024 | 134 | 12 | 9.84% |
| Sep 30, 2024 | 127 | -8 | -5.93% |
| Jun 30, 2024 | 127 | -8 | -5.93% |
| Mar 31, 2024 | 122 | -62 | -33.70% |
| Dec 31, 2023 | 122 | -62 | -33.70% |
| Jun 30, 2023 | 135 | - | - |
| Dec 31, 2022 | 184 | -133 | -41.96% |
| Dec 31, 2021 | 317 | 55 | 20.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| MindWalk Holdings | 77 |
| Xilio Therapeutics | 76 |
| PMV Pharmaceuticals | 54 |
| Pliant Therapeutics | 49 |
| Cardiff Oncology | 31 |
| Boundless Bio | 28 |
| ImageneBio | 17 |
| Context Therapeutics | 15 |
INO News
- 1 day ago - Inovio price target lowered to $4 from $6 at Piper Sandler - TheFly
- 5 days ago - INOVIO Announces Pricing of $20.0 Million Public Offering - PRNewsWire
- 5 days ago - Inovio announces common stock and warrants offering, no amount given - TheFly
- 5 days ago - INOVIO Announces Proposed Public Offering - PRNewsWire
- 4 weeks ago - Inovio files $300M mixed securities shelf - TheFly
- 4 weeks ago - Inovio Pharmaceuticals Registration statement: Registration filing - Filings
- 2 months ago - Inovio Pharmaceuticals Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Inovio price target lowered to $2.50 from $3 at H.C. Wainwright - TheFly